According to the companies, the collaboration will provide users of StarDrop – Optibrium’s lead product – with access to ICSYNTH light, an entry-level version of InfoChem’s computer-aided synthesis design (CASD) software, which enables the generation of synthesis pathways for a target molecule.
Dr. Matthew Segall, Optibrium’s CEO told us the InfoChem’s deisgn tool will be a “valuable contribution to StarDrop’s comprehensive range of optional plug-in modules.”
Segall added, “StarDrop ensures that scientists can quickly understand structure-activity relationships, identify potential liabilities and design new compounds with the highest chance of success, leading to better decisions and shorter project timelines.”
Optibrium company works closely with a range of customers and collaborators, including global pharma, biotech, and academic groups, among others. Segall in a press release that the partnership with InfoChem “continues our collaborative approach to working with leading providers of technology and services for drug discovery and other chemistry fields."
“We have developed StarDrop to seamlessly connect with a wide range of informatics systems thus giving our customers ultimate choice and flexibility, and providing everything they need for effective compound design and optimization through a single interface,” he added.
